Annual Report and AGM Notice

RNS Number : 2981F

Alliance Pharma PLC

20 April 2011

 



For immediate release

20 April 2010

 

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

Annual Report and AGM Notice

Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, is pleased to announce that its 2010 Annual Report and Notice of the Annual General Meeting, which will be held on 26 May 2011, are now available on the Company's website at www.alliancepharma.co.uk.

Printed copies of both documents have been posted to shareholders today and may also be requested by email at [e-mail].

For further information:

Alliance Pharma plc	+ 44 (0) 1249 466966
John Dawson, Chief Executive
Richard Wright, Finance Director
www.alliancepharma.co.uk
Buchanan Communications	+ 44 (0) 20 7466 5000
Mark Court / Jessica Fontaine
Numis Securities Limited	+ 44 (0) 20 7260 1000
Nominated Adviser: Michael Meade / Simon Blank
Corporate Broking: David Poutney

Notes to editors:

About Alliance

Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and, following the Cambridge Laboratories acquisition, owns or licenses the rights to more than 50 pharmaceutical products and continues to explore opportunities to expand the range.

Alliance's products are prescribed in the treatment of a wide range of conditions and include products used in the treatment of dermatological conditions, in oncology, in childbirth, in the prevention of heart disease, in Parkinson's disease, in nutrition and in nasal infections.  Alliance's sales are mainly prescription driven.  Its products are distributed to hospitals directly and to pharmaceutical wholesalers, which service both hospital and retail pharmacies with their prescription requirements.

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

 

END

 

 

MSCGMGZDKGGGMZM